[go: up one dir, main page]

AU2003260818A8 - Treatment of immune system dysfunction - Google Patents

Treatment of immune system dysfunction

Info

Publication number
AU2003260818A8
AU2003260818A8 AU2003260818A AU2003260818A AU2003260818A8 AU 2003260818 A8 AU2003260818 A8 AU 2003260818A8 AU 2003260818 A AU2003260818 A AU 2003260818A AU 2003260818 A AU2003260818 A AU 2003260818A AU 2003260818 A8 AU2003260818 A8 AU 2003260818A8
Authority
AU
Australia
Prior art keywords
treatment
immune system
system dysfunction
dysfunction
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003260818A
Other versions
AU2003260818A1 (en
Inventor
Charles Scheepers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOORE DAVID DANIEL
Original Assignee
MOORE DAVID DANIEL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOORE DAVID DANIEL filed Critical MOORE DAVID DANIEL
Publication of AU2003260818A1 publication Critical patent/AU2003260818A1/en
Publication of AU2003260818A8 publication Critical patent/AU2003260818A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003260818A 2002-11-28 2003-09-12 Treatment of immune system dysfunction Abandoned AU2003260818A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200209680 2002-11-28
ZA2002/9680 2002-11-28
PCT/IB2003/003888 WO2004047842A1 (en) 2002-11-28 2003-09-12 Treatment of immune system dysfunction

Publications (2)

Publication Number Publication Date
AU2003260818A1 AU2003260818A1 (en) 2004-06-18
AU2003260818A8 true AU2003260818A8 (en) 2004-06-18

Family

ID=32394550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003260818A Abandoned AU2003260818A1 (en) 2002-11-28 2003-09-12 Treatment of immune system dysfunction

Country Status (2)

Country Link
AU (1) AU2003260818A1 (en)
WO (1) WO2004047842A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1578271E (en) 2002-12-23 2011-08-31 Hoffmann La Roche Body fluid testing device
WO2005060951A2 (en) * 2003-12-19 2005-07-07 Bionaut Pharmaceuticals, Inc. Anti-neoplastic agents, combination therapies and related methods
DK2068873T3 (en) * 2006-09-14 2012-02-27 Bridge Biores Rights Jersey Ltd Isoniazid-mediated healing of wounds and ulcers
AP2909A (en) 2009-03-17 2014-05-31 Concert Pharmaceuticals Inc Pyrazinoisoquinoline Compounds
WO2012051633A1 (en) * 2010-10-15 2012-04-19 Tri Laz Meds Sa (Pty) Ltd The treatment of helminthic infections.
SG11201701928RA (en) 2014-09-12 2017-04-27 Antibiotx Aps Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650728B1 (en) * 1993-10-29 2002-02-27 Council of Scientific and Industrial Research Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
IT1289883B1 (en) * 1996-10-09 1998-10-19 Lupin Lab Ltd ANTI-TUBERCULAR PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PRODUCTION

Also Published As

Publication number Publication date
WO2004047842A1 (en) 2004-06-10
AU2003260818A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
PL377729A1 (en) Method of the treatment of sexual dysfunction
GB2393202B (en) Methods of well treatment
GB0225908D0 (en) Treatment of female sexual dysfunction
AU2003219981A1 (en) Benzimidazole-derivatives for the treatment of sexual dysfunction
GB2408558B (en) Treatment of pipes
GB0213869D0 (en) The treatment of pain
GB2388557B (en) Treatment system
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
AU2003260818A8 (en) Treatment of immune system dysfunction
GB0124124D0 (en) Methods of treatment
AP2004003174A0 (en) Treatment of water
AU2003234190A8 (en) Inhibition of immune complex formation
GB0210741D0 (en) Methods of therapy
GB2386555B (en) Treatment of female sexual dysfunction
EP1560592A4 (en) Treatment of hypersensitivity conditions
GB0217493D0 (en) Novel methods of treatment
GB0221712D0 (en) Methods of treatment
IL166273A0 (en) Methods of treatment of male erectile dysfunction
EP1474151A4 (en) Methods of treatment of chronic immune disease
GB0109114D0 (en) Stimulation of the immune system
AU2003276123A8 (en) Treatment of uveal melanoma
GB0213198D0 (en) Method of treatment
IL162822A0 (en) Treatment of male sexual dysfunction
GB0207091D0 (en) Method of treatment
GB0223254D0 (en) Methods of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase